PMDA — authorised 23 March 2018
- Marketing authorisation holder: Janssen Pharmaceutical KK
- Status: approved
PMDA authorised Tremfya on 23 March 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 March 2018.
Janssen Pharmaceutical KK holds the Japanese marketing authorisation.